Locations:
Search IconSearch
June 6, 2018/Neurosciences/Research

Sharper Guidance for Targeting Continuous EEG Monitoring of Critically Ill Patients

Largest study to date underscores mental status, etiology, epileptiform patterns

18-NEU-899-Newey-cEEG-Study-650×450

Among critically ill patients undergoing continuous electroencephalographic (cEEG) monitoring, mental status, the primary etiology for cEEG monitoring and epileptiform patterns are predictive of seizure risk and may help guide targeting of cEEG monitoring.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

That’s the conclusion of the largest study to date of a cohort of consecutive critically ill patients monitored with cEEG, reported by Cleveland Clinic researchers in the Journal of Clinical Neurophysiology (2018 Apr 17 [Epub ahead of print]).

The retrospective investigation found the following:

  • Seizure likelihood increased as patients’ mental status decreased. Whereas seizures were recorded in 10.3 percent of awake patients, this rate rose to 20.2 percent among lethargic patients (odds ratio [OR] = 2.21), 24.9 percent among stuporous patients (OR = 2.89) and 29.5 percent among comatose patients (OR = 3.64).
  • Seizure risk was highest in patients whose underlying reason for cEEG monitoring was a tumor; these patients’ OR for seizures was 4.65 relative to cohort patients with epilepsy, who served as a reference. Etiologies with the next-highest risks for seizures were traumatic brain injury (OR = 3.54 relative to epilepsy), CNS infection (OR = 3.52), hypoxic ischemic injury (OR = 3.14) and stroke (OR = 2.24).
  • Of three periodic epileptiform patterns evaluated on cEEG, lateralized periodic discharges were most predictive of seizure occurrence (OR = 8.27 vs. absence of epileptiform patterns). Generalized periodic discharges were somewhat predictive of seizures (OR = 2.39), but not if these generalized discharges had triphasic morphology (OR = 1.02). Seizure risk was dramatically elevated in patients with multiple epileptiform patterns (OR = 22.9).

“Acute seizures in critically ill patients have been associated with worse clinical outcomes,” says the study’s lead author, Christopher Newey, DO, MS, a staff physician in Cleveland Clinic’s Cerebrovascular Center and Epilepsy Center. “Because clinical suspicion is not always correct, cEEG monitoring is needed, but limitations in equipment and support staff make targeted monitoring increasingly important. Our findings suggest that we can better target the patients at highest seizure risk based on mental status, etiology and cEEG patterns.”

Advertisement

1,100+ patients monitored over a two-year period

The study included all critically ill adults monitored with cEEG at Cleveland Clinic over a 24-month period — 1,123 patients in total. Of these, 215 patients (19.1 percent) had a seizure recorded on cEEG, and 89.3 percent of those seizures were nonconvulsive.

These findings closely parallel those from what was previously the largest cohort study of this type, by Claassen and colleagues in 2004, which reported seizures in 19 percent of cEEG-monitored critically ill patients, of which 91.8 percent were nonconvulsive seizures. That study also found coma and lateralized periodic discharges to be associated with heightened seizure risk, and it found a number of etiologies to be associated with seizure rates similar to those in the new Cleveland Clinic study.

“These areas of concordance with this earlier study bolster confidence in the applicability of our findings to other academic centers with high-acuity critical care patients,” notes Cleveland Clinic epileptologist Stephen Hantus, MD, senior author of the current study.

Much more work to follow

The researchers found that, when present, seizures were detected within 24 hours of the start of cEEG monitoring in 92 percent of patients. The question of optimal duration of cEEG monitoring was the focus of a more recent study presented by Dr. Hantus at the American Academy of Neurology’s 2018 annual meeting, as detailed in a prior Consult QD post.

That’s just one of several avenues of ongoing or future Cleveland Clinic research in this area. “Our next step is to determine whether patient acuity predisposes to seizure risk among critically ill patients,” says Dr. Newey. “Ultimately, our goal is to create an algorithm to identify those patients at highest seizure risk prior to cEEG hookup and then create a separate algorithm to determine patients’ daily seizure risk based on EEG data.”

Advertisement

He adds that the clinical implications for neurocritical care could be substantial. “We hope this can help with triaging resources, identifying at-risk patients earlier and providing guidance on patient monitoring to other clinicians,” he concludes.

Advertisement

Related Articles

Illustration of a brain
November 6, 2024/Neurosciences/Research
Genomic Analysis Finds Connections Between Transposable Elements and Alzheimer's Disease

Understanding TE involvement is a key to developing new treatments

Man on an exercise bicycle
October 29, 2024/Neurosciences/Research
New Parkinson’s Trial Focuses on Interplay Between Exercise and Genetics

Study aims to inform an enhanced approach to exercise as medicine

researcher in dark laboratory
September 12, 2024/Neurosciences/Research
Preclinical Imaging Research Aims to Help Refine Deep Brain Stimulation for Stroke Recovery

$3.2 million grant will fund use of calcium-based imaging to record neuronal activity in ischemia model

neurons, axons and synapses in the brain
September 5, 2024/Neurosciences/Research
A Case Study in Neurotherapeutic Clinical Trial Design and Conduct

New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities

Illustration of brain activity
August 28, 2024/Neurosciences/Research
Brain Research Finds Notable Differences in Changes Based on Sex and Race

Chronic stress, asymptomatic disease affect different brains differently

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

22-NEU-2959102-CQD-Hero-650×450
June 15, 2022/Neurosciences/Research
MINDS Study Will Assess Lifestyle Interventions for Slowing Brain Pathology in Preclinical Stages

New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study

22-NEU-2671014-CQD-650×450-Type
March 9, 2022/Neurosciences/Research
A Closer Look at the Cleveland Clinic Brain Study

How the new longitudinal investigation could become the Framingham Heart Study of brain health

Ad